Welcome to our dedicated page for Bain Capital Specialty Finance SEC filings (Ticker: BCSF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bain Capital Specialty Finance, Inc. filings document the regulatory record for a New York Stock Exchange-listed business development company that lends to middle-market companies through secured debt and related investments. The company’s 8-K reports cover operating results, financial-condition announcements, dividend declarations, exhibits to press releases and other current-report events.
Its filings also describe capital-structure activity, including underwriting agreements, shelf registration materials and indenture documents for unsecured notes, as well as the common stock registered under Section 12(b). Proxy materials address annual meeting voting matters, director elections, auditor ratification and governance procedures for the externally managed BDC structure.
Bain Capital Specialty Finance, Inc. reported solid fourth-quarter 2025 results, with net investment income of $29.7M, or $0.46 per share, and earnings per share of $0.43. Regular dividends declared and payable for the quarter were $0.42 per share, supplemented by a special dividend of $0.18 per share.
As of December 31, 2025, the investment portfolio had a fair value of $2,508.4M across 203 companies, with net asset value per share of $17.23. Credit quality indicators remained stable, with non-accruals at 1.5% of amortized cost and 0.8% of fair value. The Board also declared a first-quarter 2026 dividend of $0.42 per share for stockholders of record on March 16, 2026, payable on March 30, 2026.
Bain Capital Specialty Finance (BCSF) details a highly diversified investment portfolio focused on private credit. The holdings are primarily first lien senior secured loans, including revolvers and delayed draw facilities, to borrowers across sectors such as healthcare, technology, financial services, consumer, industrials and transportation.
The schedule also shows exposure to subordinated debt, preferred equity, common equity and warrants, along with numerous forward foreign currency exchange contracts with major banks including Morgan Stanley, Wells Fargo, Bank of New York Mellon, Standard Chartered, BNP Paribas, Goldman Sachs, US Bank and Citibank. Many loans reference SOFR, EURIBOR or SONIA plus contractual spreads, with stated cash and PIK interest components and maturities generally ranging from 2025 through 2033, indicating a long-dated, floating-rate credit book diversified by industry, structure and currency.
Bain Capital Specialty Finance, Inc. is scheduling its next earnings update. The company will report financial results for the fourth quarter and fiscal year ended December 31, 2025 on February 26, 2026 after the market closes, followed by a conference call on February 27, 2026 at 8:00 a.m. Eastern Time.
The company is an externally managed business development company focused on lending to middle-market borrowers. Since beginning investment operations in 2016 and through September 30, 2025, it has invested approximately $9,688.5 million in aggregate principal of debt and equity investments.
Bain Capital Specialty Finance, Inc. entered into a Fourth Supplemental Indenture with U.S. Bank Trust Company to issue $350,000,000 aggregate principal amount of 5.950% notes due 2031.
The Notes mature on March 1, 2031, bear interest at 5.950% per year, and pay interest semi-annually on March 1 and September 1, beginning September 1, 2026. They are general unsecured obligations, ranking senior to expressly subordinated debt, equal with other unsecured unsubordinated debt, effectively junior to secured debt up to the value of collateral, and structurally junior to liabilities of subsidiaries.
The Indenture includes asset coverage and reporting covenants and requires a repurchase offer at 100% of principal plus accrued interest upon a defined change of control repurchase event. The registered offering closed on January 29, 2026 and generated net proceeds of about $342.5 million, which the Company intends to use to repay outstanding secured indebtedness under its financing arrangements and for general corporate purposes.
Bain Capital Specialty Finance, Inc. is issuing $350,000,000 aggregate principal amount of 5.950% senior unsecured notes due March 1, 2031. The notes are priced at 98.935% of face value, pay interest semi-annually on March 1 and September 1 beginning September 1, 2026, and may be redeemed by the company at any time, including at par on or after February 1, 2031, or at a make-whole premium before that date.
The notes rank pari passu with the company’s other unsecured unsubordinated debt, effectively junior to secured borrowings and structurally junior to subsidiary obligations. As of September 30, 2025, total consolidated indebtedness was about $1.5 billion, including approximately $0.5 billion of secured debt and $0.1 billion at subsidiaries. Net proceeds of approximately $342.5 million are expected to be used to repay outstanding secured indebtedness under existing financing arrangements and for general corporate purposes.
Investors receive a change-of-control repurchase right at 100% of principal plus accrued interest if a defined Change of Control Repurchase Event occurs. The notes are not insured by any government agency and are not expected to be listed on any securities exchange, so liquidity will depend on dealer market-making. The company operates as an externally managed business development company focused on senior and mezzanine lending to middle-market borrowers.
Bain Capital Specialty Finance, Inc. entered into an underwriting agreement to issue and sell $350 million aggregate principal amount of its 5.950% Notes due 2031. The agreement is with BCSF Advisors, LP and a group of underwriters led by Wells Fargo Securities, LLC, J.P. Mogan Securities LLC, and SMBC Nikko Securities America, Inc. It contains customary representations, warranties, covenants, indemnification, and contribution provisions for all parties. The notes offering is being conducted under the company’s effective shelf registration statement on Form N-2, using a preliminary and final prospectus supplement each dated January 22, 2026.
Bain Capital Specialty Finance, Inc. plans a public offering of new senior unsecured notes that will pay fixed cash interest semi-annually and mature on a specified future date. The notes may be redeemed early at the company’s option and investors can require repurchase at 100% of principal plus accrued interest if a defined Change of Control Repurchase Event occurs.
The notes will rank equally with the company’s other unsecured unsubordinated debt, be effectively junior to secured borrowings, and structurally junior to obligations of subsidiaries. As of September 30, 2025, total consolidated indebtedness was approximately $1.5 billion, including about $0.5 billion of secured debt and $0.9 billion of direct unsecured indebtedness.
The company expects to use net proceeds primarily to repay outstanding secured indebtedness under its existing financing arrangements and for general corporate purposes, with future borrowings potentially used to fund investments in portfolio companies. The notes are not expected to be listed on an exchange, and an active trading market may not develop.
Bain Capital Specialty Finance, Inc. declared a special cash dividend of $0.15 per share. This one-time dividend will be paid to stockholders who are on the company’s books as of the record date of December 31, 2025, and is scheduled to be paid on January 26, 2026. The company disclosed this action in connection with a press release that provides additional details.
Bain Capital Specialty Finance (NYSE: BCSF) announced that it furnished a press release with its financial results for the third quarter ended September 30, 2025. The company also declared a fourth fiscal quarter 2025 dividend of $0.42 per share and confirmed an additional dividend of $0.03 per share that was previously announced.
Both the $0.42 regular dividend and the $0.03 additional dividend are payable on December 30, 2025 to stockholders of record as of December 16, 2025. These distributions outline the company’s planned cash return to shareholders for the quarter while results details are provided in the accompanying press release.
BCSF provides a detailed look at its investment portfolio, which is built mainly around first lien senior secured loans, including term loans, revolvers and delayed draw facilities. These positions span many industries such as healthcare, technology, transportation, consumer, industrials and financial services, with borrowers across U.S. and international markets.
The schedule also lists subordinated debt, preferred equity, common equity interests and warrants in various portfolio companies. Many loans are floating rate, referencing SOFR, SONIA, EURIBOR, BBSY, CORRA, NIBOR or Prime, with stated credit spreads that in several cases exceed 5% and include payment‑in‑kind (PIK) features.
Alongside corporate credit investments, BCSF holds multiple forward foreign currency exchange contracts with counterparties such as Morgan Stanley, Standard Chartered, Wells Fargo, Bank of New York Mellon, BNP Paribas, US Bank and Citibank, plus an interest rate swap with Wells Fargo. Maturities for these loans and derivatives generally extend from 2025 into the early 2030s.